Comparison of once-daily, niacin extended-release/lovastatin with standard doses of atorvastatin and simvastatin (the ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE]). (Q44359910)

From Wikidata

Jump to navigation Jump to search

scientific article published in March 2003

Language	Label	Description	Also known as
English	Comparison of once-daily, niacin extended-release/lovastatin with standard doses of atorvastatin and simvastatin (the ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE]).	scientific article published in March 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Comparison of once-daily, niacin extended-release/lovastatin with standard doses of atorvastatin and simvastatin (the ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE]). (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Harold E Bays

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Carlos A Dujovne

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Mark E McGovern

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

T Eric White

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Moti L Kashyap

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

A Gene Hutcheson

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

John R Crouse

7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation

8

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

0 references

publication date

1 March 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

91

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

667-672

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900007-9

7 January 2021

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900007-9

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900007-9

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900007-9

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900007-9

7 January 2021

Existing and investigational combination drug therapy for high-density lipoprotein cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900007-9

7 January 2021

Mechanism of action of niacin on lipoprotein metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900007-9

7 January 2021

Statins: effective antiatherosclerotic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900007-9

7 January 2021

Efficacy and Tolerability of Low-dose Simvastatin and Niacin, Alone and in Combination, in Patients With Combined Hyperlipidemia: A Prospective Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900007-9

7 January 2021

Comparison of lovastatin (20 mg) and nicotinic acid (1.2 g) with either drug alone for type II hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900007-9

7 January 2021

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900007-9

7 January 2021

Plasma high density lipoprotein subfractions in subjects with different coronary risk indices as assessed by plasma lipoprotein concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900007-9

7 January 2021

Efficacy and safety of an extended-release niacin (Niaspan): a long-term study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900007-9

7 January 2021

Identifiers

10.1016/S0002-9149(03)00007-9

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44359910&oldid=1533673819"